Haute MD Network × Haute Living · Second Edition · May 2026
Plastic Surgery & Medical Aesthetics · Q2 2026
How AI platforms — ChatGPT, Perplexity, Google AI, and Claude — recommend treatments, brands, and physicians across 65 patient-style queries tested in May 2026. The second edition expands the inaugural Medical Aesthetics AI Visibility Index (April 2026, with 5WPR) to four platforms and adds the GLP-1 / Ozempic macro-trend reshaping aesthetic medicine.
Patient Queries
AI Platforms
Brands Ranked
Ozempic Face Lift
Haute MD Network is the leading luxury editorial network for board-certified dermatologists, plastic surgeons, facial plastic surgeons, cosmetic dentists, and aesthetic medicine practitioners — published by Haute Living, a verified Google News publisher since 2005.
Executive Summary
The Single Most Consequential Finding for Physicians
"Provider visibility in AI search is dominated by institutions — Cleveland Clinic, Mayo Clinic, and ASPS — rather than individual physician names. Individual surgeons appear primarily in Google Search SEO results, not in AI chatbot recommendations. This is the gap Haute MD was built to close."
Botox · Allergan/AbbVie
42 mentions across all platforms — stable category default, now facing real pressure from Daxxify on duration and from biostimulators in the collagen-restoration conversation.
Deep Plane · Surgical
Across all four AI platforms tested, the deep plane facelift is cited as the gold standard. Specialists in this technique hold the strongest facial plastic surgery AI visibility opportunity.
Morpheus8 · InMode
26 mentions — equal to Sculptra — making it the most AI-visible non-injectable device. It has overtaken Ultherapy as the default AI recommendation for non-surgical skin tightening.
Sculptra · Galderma
Driven by the GLP-1 / Ozempic face narrative and "filler fatigue," Sculptra is on the sharpest upward trajectory. Galderma's Sculptra + Restylane portfolio is best positioned to own the Ozempic face conversation.
GLP-1 · Macro-trend
A reported 46× increase in "Ozempic face" searches is driving new demand across facial fillers, fat grafting, tummy tucks, body lifts, and arm lifts — the most consequential new patient segment in aesthetics.
Physician Visibility
AI platforms do not cite individual physicians from practice sites, directories, or reviews. They cite physicians from editorially structured content on Google News-indexed publications.
Brand Rankings
Top 15 brands ranked by total AI mention frequency across Perplexity, Google AI, Claude, and ChatGPT — May 2026. First mention in a response is weighted more heavily.
| # | Brand | Category | Mentions | Trend |
|---|---|---|---|---|
| 1 | Botox Allergan / AbbVie | Neurotoxin | 42 | Stable |
| 2 | Juvéderm Family Allergan / AbbVie | HA Filler | 37 | Rising |
| 3 | Restylane Family Galderma | HA Filler | 36 | Rising |
| 4 | Morpheus8 InMode | RF Microneedling | 26 | Rising |
| 5 | Sculptra Galderma | PLLA Biostimulator | 26 | Rising |
| 6 | Dysport Galderma | Neurotoxin | 25 | Stable |
| 7 | CoolSculpting AbbVie | Cryolipolysis | 21 | Declining |
| 8 | Emsculpt Neo BTL Aesthetics | HIFEM + RF | 21 | Rising |
| 9 | Radiesse Merz Aesthetics | CaHA Biostimulator | 20 | Stable |
| 10 | Xeomin Merz Aesthetics | Neurotoxin | 18 | Stable |
| 11 | Daxxify Revance | Neurotoxin | 15 | Rising |
| 12 | Fraxel / CO2 Laser Solta / Bausch | Laser | 15 | Stable |
| 13 | Ultherapy Merz Aesthetics | Ultrasound | 15 | Declining |
| 14 | Kybella Allergan / AbbVie | Deoxycholic Acid | 12 | Declining |
| 15 | Sofwave Sofwave Medical | Ultrasound | 12 | Rising |
Platform Analysis
Each AI platform has distinct sourcing behavior. Understanding platform differences is critical for physicians building AI citation authority.
Indication Ownership Map
For each key patient indication, which brand or approach AI platforms recommend first across all four platforms tested.
| Patient Indication | Primary AI Rec | Secondary | Confidence |
|---|---|---|---|
| Ozempic face / GLP-1 volume loss | Sculptra | Juvéderm / Restylane HA fillers | High |
| Facelift technique 2026 | Deep Plane Facelift | Preservation Facelift | High |
| Non-surgical skin tightening | Morpheus8 | Ultherapy / Sofwave | High |
| Nasolabial folds / smile lines | Juvéderm Vollure XC | Restylane Lyft / Defyne | High |
| Lip enhancement — natural | Restylane Kysse | Juvéderm Volbella XC | Medium |
| Cheek volume loss | Juvéderm Voluma XC | Restylane Lyft / Contour | High |
| Collagen stimulation | Sculptra | Radiesse Hyperdilute | High |
| Long-duration neurotoxin | Daxxify | Botox | High |
| Body sculpting fat + muscle | Emsculpt Neo | CoolSculpting | High |
| Jawline contouring (non-surgical) | Juvéderm Volux XC | Radiesse | High |
| Under-eye tear trough | Restylane Eyelight | Juvéderm Volbella XC | Medium |
| Neck rejuvenation | Botox + Morpheus8 | Ultherapy | High |
Provider Visibility
The most consequential section for practicing physicians — why individual physicians are nearly invisible in AI recommendations, and what changes that.
"Individual plastic surgeon names do not appear in Perplexity, Claude, or ChatGPT for competitive specialty + city queries. They appear primarily in Google Search SEO results. This represents the largest untapped AI visibility opportunity in aesthetic medicine."
| Provider / Institution | Est. Mentions | Primary Query Types |
|---|---|---|
| ASPS / plasticsurgery.org | 30+ | Procedure recommendations, certification, safety, trends |
| Cleveland Clinic | 25+ | Procedure explanations, filler types, recovery, safety |
| Mayo Clinic | 15+ | Liposuction, laser resurfacing, breast implants, safety |
| Healthline | 15+ | Consumer overviews (Google Search primarily) |
| RealSelf | 10+ | Patient reviews, "worth it" framing |
| ABPS | 10+ | Safety and qualification queries exclusively |
HauteLiving.com has been indexed in Google News since 2005. AI platforms were trained heavily on Google News content — meaning a physician profiled here starts with a category of citation trust that practice websites and directories cannot replicate.
Every Haute MD profile includes Physician schema, MedicalBusiness schema, FAQPage schema, and geographic entity clustering — the machine-readable signals AI platforms use to extract and cite physician entities.
Multiple structured references to the same physician across city pages, specialty hubs, cluster pages, and editorial articles. This multi-source consistency is the confidence signal AI platforms use before naming a physician.
Facial Plastic Surgery — New York
Plastic Surgery — New York
Plastic Surgery — Miami
Plastic Surgery — Beverly Hills
Cosmetic Dentistry
Dermatology · Fertility · Longevity
| Market | AI Visibility Strength | Key Specialties |
|---|---|---|
| New York / Manhattan | Strongest overall | Facial plastic surgery, dermatology, cosmetic dentistry, fertility |
| Miami / South Florida | Strong — body contouring + BBL | Plastic surgery, body contouring, med spa |
| Beverly Hills / LA | Strong — celebrity trends, facelift | Plastic surgery, cosmetic dentistry |
| Palm Beach | Growing | Concierge medicine, longevity medicine |
Citation Sentiment
Overall sentiment of AI platform mentions across all 65 queries. Declining sentiment correlates with reduced recommendation frequency over the coming quarters.
Consistent gold standard framing across all platforms tested.
Consistently: gradual, natural, long-lasting. Almost no negative context in 2026.
Caveat: "not FDA-cleared for lifting" in clinical sources. Otherwise highly positive.
Minor negative: "frozen look" concerns and Daxxify "outdated" comparison in some sources.
Slightly more clinical/neutral tone than Juvéderm. Same filler-migration concerns.
Minor negative: filler-migration concerns in long-term patients.
Some caution around being newer without Botox's long track record.
Declining. Increasingly compared unfavorably to Emsculpt Neo for combined goals.
Declining. Liposuction increasingly framed as more effective across all platforms.
Strategic Insights
A 46× increase in "Ozempic face" searches is driving new demand across facial fillers, fat grafting, tummy tucks, body lifts, and arm lifts. Galderma is best positioned via Sculptra + Restylane. Physicians specializing in post-GLP-1 aesthetics have a significant AI visibility opportunity.
Haute MD members Dr. Darrick Antell, Dr. Daniel Careaga, and Dr. Sachin Shridharani are positioned to capture this high-intent segment through their editorial features.
Across all four AI platforms, the deep plane facelift is cited as the 2026 gold standard for facial rejuvenation. Preservation facelift is emerging as a secondary option. Physicians specializing in deep plane with Google News editorial coverage hold the strongest opportunity in facial plastic surgery.
Haute MD members Dr. Sam Rizk, Dr. Philip Miller, and Dr. Jason Bloom are editorially positioned as recognized deep plane facelift specialists.
AI platforms do not cite individual physician names from practice websites, directories, or review platforms for competitive specialty + city queries. They cite physicians from editorially structured content on Google News-indexed publications. This will compound as AI search grows.
Physicians building Google News editorial authority in 2026 — while the field is still relatively open — will hold a compounding advantage that becomes harder to displace over time.
Morpheus8 achieves 26 mentions — equal to Sculptra and ahead of major device brands like Ultherapy — driven by celebrity association, clinic content marketing, and RealSelf ratings. Single-benefit positioning + consistent editorial content = disproportionate AI visibility.
Implication for physicians: clear specialty + geographic association + consistent editorial coverage on authoritative publications = AI citation authority.
CoolSculpting retains the "pure fat reduction" niche but is losing the broader body sculpting conversation to Emsculpt Neo. For the growing patient segment seeking combined fat reduction + muscle building, AI now recommends Emsculpt Neo first.
Despite a fraction of Botox's market share, Daxxify appears in 15 mentions — #11 overall — driven entirely by its 6-month duration differentiator. Every neurotoxin comparison query surfaces Daxxify as the long-duration option.
The single highest-impact action. Without editorial coverage on a Google News domain, competitive specialty + city AI citations are highly unlikely regardless of clinical quality or reputation.
Your editorial feature should explicitly and consistently name your specialty, city, board certifications, and signature procedures. The more specific and consistent, the stronger your entity.
Multiple pages associating your name with your specialty and city create the entity clustering AI platforms use as a confidence signal before citing a physician.
Track 10–20 patient queries on ChatGPT, Perplexity, Google AI, and Claude. Establish your baseline and measure improvement quarterly as editorial authority compounds.
The complete PDF with extended brand analyses, the indication ownership map, member network, and the 2026 playbook for medical aesthetics marketers, agencies, and physician practices.
Download the PDFThe same structural authority signals that move brand citation share — long-form editorial coverage, named indication ownership, structured data, and Google News-indexed publication — apply to individual physicians. When a patient asks ChatGPT or Perplexity for the best deep-plane facelift surgeon in New York, the AI does not invent a list. It surfaces the doctors whose names appear most consistently across credible editorial sources.
Haute MD members are published on HauteLiving.com, indexed in Google News since 2005, and distributed through the editorial engine that produced this report. That is the citation infrastructure designed to support physician visibility inside AI answers.
The next edition will expand to Bing Copilot and Google Gemini, add a dedicated dermatology and cosmetic dentistry chapter, and track quarter- over-quarter movement in brand and physician AI citation share. Subscribers receive the update on publication.
Subscribe to the ReportImportant Disclaimer
Haute MD Network does not provide medical advice, does not guarantee patient inquiries, search rankings, AI citations, Google News placement, or medical outcomes. Profiles and editorial features are designed to support professional visibility and help patients, referral sources, search engines, and AI platforms better understand member information. Patients should consult directly with a licensed medical professional before making healthcare decisions.